Definium Theraputics Inc (DFTX)

[MomsSpaghetti]

MindMed is harnessing the power of artificial intelligence (AI) and large language models (LLMs) to analyze Hamilton Anxiety Rating Scale (HAM-A) scores from its Phase 3 clinical trials involving LSD-based therapies. By leveraging these advanced technologies, the company aims to uncover deeper insights into patient responses, improve the precision of outcome assessments, and accelerate the path to regulatory approval for novel psychedelic treatments targeting anxiety disorders. Pretty cool stuff.